Award winners for Best Practices in Hepatitis C Virus Care:
Infectious Disease Management
Read our Reports and Recommendations
Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. In 2018, an estimated 59,100 Washingtonians were living with HCV, prompting Governor Inslee to issue Directive of the Governor 18-13: “Eliminating Hepatitis C in Washington in 2030 through combined public health efforts and a new medication purchasing approach.”
| Name | Title | Organization |
| Abha Puri, MPH | Program Manager | Community Health Plan of Washington |
| Emalie Huriaux, MPH | STD, Adult Hepatitis, and Syringe Service Program (SSP) Manager | WA Department of Health |
| John Scott, MD, MSc | Professor, Department of Medicine Medical Director, Telehealth Associate Medical Director, Liver Clinic |
University of Washington |
| Jon Stockton, MHA | Adult Viral Hepatitis Coordinator | WA Department of Health |
| Judith Tsui, MD, MPH | Associate Professor, Department of Medicine Director, UW Medical Student Addiction Research Program |
University of Washington |
| Melda Velasquez | Service Line Director | Kadlec Regional Medical Center |
| Omar Daoud, PharmD | Director of Pharmacy | Community Health Plan of Washington |
| Patrick Judkins | Education and Outreach Specialist, Disease Control and Prevention | Thurston County Health Department |
| Ryan Pistoresi, PharmD, MS | Assistant Chief Pharmacy Officer | Washington State Health Care Authority |
| Wendy Wong, BSc | Ambulatory Clinical Pharmacist | Providence Health and Services |
| Vania Rudolph, MD, MPH | Addiction Medicine Specialist | Swedish Health Centers |
| Yumi Ando, MD | Gastroenterologist | Kaiser Permanente |
Award winners for Best Practices in Outpatient Infection Control:
Read our Report and Recommendations
The past several decades have seen a significant shift in healthcare delivery from inpatient to outpatient settings, yet outpatient settings often lack the infrastructure or resources to support infection prevention and surveillance activities. The COVID-19 pandemic has demonstrated the importance of infection control measures, as the first confirmed case in the United States was in Washington, and as of December 2021 over 800,000 Washingtonians have been infected. At the same time, strong infection control policies and procedures like physical distancing and masking have disrupted the circulation of other respiratory viruses and infectious diseases. This workgroup will review existing, often inpatient, infection control guidelines and translate them to outpatient settings.
Read our Charter
Workgroup Members
| Name | Title | Organization |
| Mark Haugen, MD (chair) | Family Medicine Physician | Walla Walla Clinic & Surgical Center |
| Anne Sumner, BSN, MBA | VP Head of Operations | Baker Boyer Bank |
| Cathy Carroll | Washington Health Care Authority | |
| Faiza Zafar, DO, FACOI | Medical Director | Community Health Plan of Washington |
| Larissa Lewis, MPH, CIC | HAI Education and Guidance Development Supervisor | WA Department of Health |
| Lisa Hannah, RN, CIC | Infection Prevention Team Supervisor | WA Department of Health |
| Lisa Waldowski, DNP, CIC | Regional Director, Infection Prevention and Control | Kaiser Permanente |
| Rhonda Bowen, CIC, CPPS, CPHQ | Senior Improvement Advisory, Patient Safety | Comagine Health |
| Stephanie Jaross, BSN, RN | ASC Director | Proliance Center for Outpatient Spine and Joint Surgery |
| Sierra Bertolone-Smith, MDc | Medical Student | Pacific Northwest University of Health Sciences |
© 2024 Foundation for Health Care Quality | Privacy Statement | Disclaimer